Biotechnology
Intellectual property protection is critical for the successful development and commercialisation of biotech innovations. The cycle for product development, testing, clinical trials, governmental approval and commercialisation is lengthy and requires enormous monetary and resource investment. However, the risks, potential market and returns are huge.
Stephens Lawyers works with emerging and established biotechnology companies to develop and implement strategies to protect their technology through patent, confidential information/trade secret or contractual protection. The firm also provides strategic advice to minimise the risk of infringement of third party patents and intellectual property.
Stephens Lawyers assists with the negotiation and preparation of:
- Collaborative research agreements
- Licence agreements
- Confidentiality/non-disclosure agreements
- Joint ventures
- Technology transfer agreements
- Marketing and distribution agreements.
Our extensive litigation practice enables us to represent companies in patent and intellectual property infringement claims and disputes involving the unauthorised use of confidential information/trade secrets and ownership of intellectual property.